Abstract
Self-monitoring of blood glucose (SMBG) has been recommended for people with type 2 diabetes mellitus. This trial tested an automated self-management monitor (ASMM) that reminds patients to perform SMBG, provides feedback on results of SMBG, and action tips for improved self-management. This delayed-start trial randomized participants to using the ASMM immediately (IG), or following a delay of 6months (DG). Glycated hemoglobin (HgbA1c) level and survey data was collected at home visits every 3months. 44 diabetic men and women, mean age 70, completed the 12-month trial. Baseline HgbA1c was 8.1%±1.0, dropping to 7.3±1.0 by 9months, with a 3-month lag in the DG (F=3.56, p=0.004). Decrease in HgbA1c was significantly correlated to increased frequency of SMBG, R=0.588, p<0.01. Providing older diabetics with objective immediate contingent feedback resulted in more frequent SMBG that correlated with better glycemic control. This type of technology may provide real-time feedback not only to patient users, but to the health care system, allowing better integration of provider recommendations with patient-centered action.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
